BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2017 6:54:48 AM | Browse: 1342 | Download: 2706
 |
Received |
|
2017-05-31 01:43 |
|
Peer-Review Started |
|
2017-05-31 01:53 |
|
To Make the First Decision |
|
2017-06-22 02:39 |
|
Return for Revision |
|
2017-06-22 05:29 |
|
Revised |
|
2017-07-03 05:12 |
|
Second Decision |
|
2017-07-06 11:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-07-12 04:14 |
|
Articles in Press |
|
2017-07-12 04:14 |
|
Publication Fee Transferred |
|
2017-07-20 06:06 |
|
Edit the Manuscript by Language Editor |
|
2017-07-27 10:13 |
|
Typeset the Manuscript |
|
2017-08-18 07:13 |
|
Publish the Manuscript Online |
|
2017-08-28 06:54 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yan Xue, Li-Xin Zhang, Lei Wang, Tao Li, Yun-Dong Qu and Feng Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Project of Science and Technology Development Plan of Ji'nan city |
201506004 |
| Youth Fund of 2nd Hospital of Shandong University |
Y2014010014 |
|
| Corresponding Author |
Lei Wang, MD, PhD, Professor, Department of Infectious Diseases and Hepatology, the Second Hospital of Shandong University, 247 Beiyuan Road, Jinan 250033, Shandong Province, China. wlcrb@sdu.edu.cn |
| Key Words |
Hepatitis C virus; Sofosbuvir; Daclatasvir; Kidney transplantation; Direct-acting antivirals |
| Core Tip |
This is a prospective study to assess the efficacy and safety of sofosbuvir and daclatasvir regimens for kidney transplantation (KT) patients with hepatitis C virus (HCV) infection. This study enrolled a prospective cohort of consecutive Chinese KT patients with HCV infection. The recipients were given sofosbuvir combined with daclatasvir with or without ribavirin. Sofosbuvir and daclatasvir treatments are highly efficient and safe. Patients tolerated the regimens and no serious adverse events were observed. Larger prospective cohort studies are needed to validate these results. |
| Publish Date |
2017-08-28 06:54 |
| Citation |
Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i32/5969.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i32.5969 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
